Stockscreener 앱 받기
13.90
1.21%
-0.17
Axogen Inc 주식(AXGN)의 최신 뉴스
Axogen Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Ichimoku Cloud Indicates Uncertainty Around Axogen Inc.Expert Verified Stock Trade Ideas Backed by Data - beatles.ru
Axogen Inc Reports Strong Q2 2025 Earnings with 18.3% Revenue Growth and BLA Approval Expected in September - AInvest
AxoGen’s Earnings Call: Strong Growth Amid Challenges - The Globe and Mail
Axogen 2025 Q2 Earnings Returns to Profitability with 130.1% Net Income Jump - AInvest
Axogen raises 2025 revenue growth target to at least 17% as BLA approval nears - MSN
AxoGen price target lowered to $20 from $21 at Raymond James - TipRanks
AxoGen, Inc. (NASDAQ:AXGN) Q2 2025 Earnings Call Transcript - Insider Monkey
Axogen Reports Strong Q2 2025 Financial Results - The Globe and Mail
AxoGen: Q2 Earnings Snapshot - Stamford Advocate
Axogen Inc (AXGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Axogen, Inc. Reports Strong Revenue Growth in Q2 2025 - TipRanks
Axogen (AXGN) Q2 Revenue Jumps 18% - AOL.com
AxoGen stock price target lowered to $20 by Raymond James on BLA timing - Investing.com Canada
Axogen (AXGN.O) Sees Sharp Intraday Move—What's Driving the Volatility? - AInvest
AxoGen reports Q2 adjusted EPS 12c, consensus 6c - TipRanks
AxoGen Q2 2025 Earnings Call Transcript - MarketBeat
Jefferies raises AxoGen stock price target to $25 on strong sales growth - Investing.com Australia
Axogen's Q2 2025 Earnings Call: Unpacking Contradictions in Margins, BLA Milestones, and Growth Strategies - AInvest
Axogen Boosts 2025 Revenue Growth Target to at Least 17% Ahead of BLA Approval. - AInvest
Axogen, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:AXGN) - Seeking Alpha
Axogen (AXGN.O) Sees Sharp Intraday Spike—What’s Driving the Volatility? - AInvest
AxoGen's Q2 Earnings Exceed Expectations with Strong Financial TurnaroundNews and Statistics - IndexBox
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Axogen Inc earnings beat by $0.06, revenue topped estimates - Investing.com Australia
Axogen's Q2 2025 Financial Outlook and Strategic Position in the Peripheral Nerve Repair Market - AInvest
Axogen, Inc. Reports Second Quarter 2025 Financial Results - The Manila Times
Should I hold or sell Axogen Inc. stock in 2025Dynamic portfolio growth - Jammu Links News
Is it the right time to buy Axogen Inc. stockBreakthrough stock performance - Jammu Links News
Is Axogen Inc. a good long term investmentCapitalize on emerging investment opportunities - Jammu Links News
What catalysts could drive Axogen Inc. stock higher in 2025Spectacular growth rates - Jammu Links News
What institutional investors are buying Axogen Inc. stockConsistently high returns - Jammu Links News
What is the dividend policy of Axogen Inc. stockUnlock powerful market trend analysis - Jammu Links News
What are Axogen Inc. company’s key revenue driversAchieve consistent profits with expert advice - Jammu Links News
What markets is ENTX expanding into Is Axogen Inc. stock a good long term investment optionRemarkably fast returns - Jammu Links News
What are the latest earnings results for Axogen Inc.Build a strong portfolio for growth and safety - Jammu Links News
Why Axogen Inc. stock attracts strong analyst attentionFree Wealth Building Stock Market Ideas - Newser
Price momentum metrics for Axogen Inc. explainedFree Opportunity Map for Daily Stock Trading - Newser
AXOGEN In Buyout Talks? $18 Per Share Bid Sparks Market Buzz! - Smartkarma
Axogen gains on report of takeover interest - MSN
Axogen, Inc. (NASDAQ:AXGN) Stock Rockets 28% But Many Are Still Ignoring The Company - 富途牛牛
Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight - GlobeNewswire Inc.
What candlestick patterns are forming on Axogen Inc.Stock Portfolio Risk and Return Analysis - Newser
Chart based exit strategy for Axogen Inc.Stable Swing Setup with Safety Analysis - Newser
Axogen Experiences Possible Sale After Strategic Buyer Approach at $18 Per Share - AInvest
1.17%
자본화:
|
볼륨(24시간):